Back to search

United States· US:67457-475_8c9683a0-197a-4291-9dc1-fd7ce5723efe

VECURONIUM BROMIDE

A vecuronium product containing vecuronium bromide, registered in United States by Mylan Institutional LLC. The same ATC class is registered in 6 of our 19 countries.

ATC M03AC03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedVECURONIUM BROMIDEATCM03AC03REGISTER NO.US:67457-475_8c9683a0…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Vecuronium is registered in 6 of 19 countries.

Countries holding a registration under ATC M03AC03 (vecuronium), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose

Vecuronium · ATC M03AC03

6 / 19 countries

  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
VECURONIUM BROMIDE
Manufacturer
Mylan Institutional LLC
Country
United States (US)
ATC code
M03AC03
ATC class
Vecuronium
Defined daily dose
6.3 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    67457-475-20
  • ndc11
    6745747520
    10 VIAL in 1 CARTON (67457-475-20) / 20 mL in 1 VIAL (67457-475-00)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

125 interactions on record for vecuronium.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vecuronium · interactions on record

125 records

  • 12 severe
  • 59 moderate
  • 4 minor
  • 50 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vecuronium in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vecuronium products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Vecuronium Bradex, Vecuronium Inresa
  • United Kingdom (Northern Ireland) · Vecuronium Bromide, Vecuronium Bromide Bradex
  • Greece · Vecurol
  • Croatia · Veculex
  • Netherlands · Vecuronium Sun
  • Portugal · Brometo De Vecurónio Bradex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c29ae20c-3584-46a6-bc9b-eecb9ce481f5
GET /v1/drugs/c29ae20c-3584-46a6-bc9b-eecb9ce481f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "VECURONIUM BROMIDE",
  "productndc": "67457-475",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA090243",
  "marketing_category": "ANDA"
}

See everything about vecuronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.